These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16329660)

  • 1. Role of hepatitis C virus in cardiomyopathies.
    Matsumori A
    Ernst Schering Res Found Workshop; 2006; (55):99-120. PubMed ID: 16329660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection and heart diseases: a multicenter study in Japan.
    Matsumori A; Ohashi N; Hasegawa K; Sasayama S; Eto T; Imaizumi T; Izumi T; Kawamura K; Kawana M; Kimura A; Kitabatake A; Matsuzaki M; Nagai R; Tanaka H; Hiroe M; Hori M; Inoko H; Seko Y; Sekiguchi M; Shimotohno K; Sugishita Y; Takeda N; Takihara K; Tanaka M; Yokoyama M
    Jpn Circ J; 1998 May; 62(5):389-91. PubMed ID: 9626910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C virus infection and cardiomyopathy].
    Matsumori A
    Nihon Rinsho; 1999 Feb; 57(2):455-63. PubMed ID: 10078023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C associated cardiomyopathy: potential pathogenic mechanisms and clinical implications.
    Sanchez MJ; Bergasa NV
    Med Sci Monit; 2008 May; 14(5):RA55-63. PubMed ID: 18443562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of HCV heart diseases.
    Haykal M; Matsumori A; Saleh A; Fayez M; Negm H; Shalaby M; Bassuony S
    Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):493-499. PubMed ID: 33861939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy.
    Matsumori A; Yutani C; Ikeda Y; Kawai S; Sasayama S
    Lab Invest; 2000 Jul; 80(7):1137-42. PubMed ID: 10908160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocarditis and heart failure associated with hepatitis C virus infection.
    Matsumori A; Shimada T; Chapman NM; Tracy SM; Mason JW
    J Card Fail; 2006 May; 12(4):293-8. PubMed ID: 16679263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA and hepatitis C virus positive cardiomyopathy].
    Naruse TK; Inoko H
    Nihon Rinsho; 2000 Jan; 58(1):212-7. PubMed ID: 10885316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection and cardiomyopathies.
    Matsumori A
    Circ Res; 2005 Feb; 96(2):144-7. PubMed ID: 15692092
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic variant of myocarditis associated with hepatitis C virus infection.
    Okabe M; Fukuda K; Arakawa K; Kikuchi M
    Circulation; 1997 Jul; 96(1):22-4. PubMed ID: 9236410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
    Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
    Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer aspects of pathogenesis of heart failure: hepatitis C virus infection in myocarditis and cardiomyopathy.
    Matsumori A; Sasayama S
    J Card Fail; 1996 Dec; 2(4 Suppl):S187-94. PubMed ID: 8951578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus and cardiomyopathy.
    Matsumori A
    Herz; 2000 May; 25(3):249-54. PubMed ID: 10904847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide.
    Matsumori A
    Jpn Circ J; 1997 Apr; 61(4):275-91. PubMed ID: 9152779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus.
    Matsumori A
    Intern Med; 2001 Feb; 40(2):182-4. PubMed ID: 11300163
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy.
    Frustaci A; Calabrese F; Chimenti C; Pieroni M; Thiene G; Maseri A
    Chest; 2002 Oct; 122(4):1348-56. PubMed ID: 12377863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy.
    Takeda A; Sakata A; Takeda N
    Mol Cell Biochem; 1999 May; 195(1-2):257-61. PubMed ID: 10395090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.
    Thursz M; Yallop R; Goldin R; Trepo C; Thomas HC
    Lancet; 1999 Dec 18-25; 354(9196):2119-24. PubMed ID: 10609818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview on chronic viral cardiomyopathy/chronic myocarditis.
    Schultheiss HP; Kühl U
    Ernst Schering Res Found Workshop; 2006; (55):3-18. PubMed ID: 16329654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.